Strategy

People On The Move: Appointments At PAGB, Enzymatica, Marinomed

 
• By 

A round-up of the latest European people moves: PAGB names new president; Enzymatica hires marketing & sales director; Marinomed strengthens supervisory board.

Bayer And GSCF Paper Outlines ‘Practical Actions’ For Scaling Self-Care Globally

 
• By 

Bayer Consumer Health, the Global Self-Care Federation and the Business Council for International Understanding outline in a paper how industry can work with multilateral organizations, governments, financial institutions, and stakeholders to "recognize and champion self-care as a fundamental driver of global health progress."

Alliance Pharma Set To Be Snapped Up By Private Equity

 
• By 

Offer valuing struggling UK consumer health player Alliance at £350m has the backing of the company's board of directors.

Stada Makes Chairman Appointment Laying Groundwork For IPO

 
• By 

Stada has made the strongest indication yet that it is preparing for an initial public offering, appointing Andreas Fibig as independent chairman of a board of directors that will be established “in the event of an IPO.”


People On The Move: Appointments At Maxwellia, Reckitt, Barentz

 
• By 

A round-up of the latest European consumer health appointments: Maxwellia adds CFO and board member; Reckitt restructures operations; Barentz names CEO.

‘We All Have To Start Somewhere’: How Retailers Are Shaping Perrigo’s Climate Ambitions

 
• By 

Perrigo's retail customers are expecting real "net zero" progress from consumer health manufacturers, which is in turn driving the firm's sustainability ambitions and expectations from their own suppliers, Perrigo’s UK ethical compliance lead Isobel Gay tells HBW Insight in this exclusive interview.

People On The Move: Appointments At Boiron, Dr. Theiss, ProBiotix

 
• By 

A round-up of the latest European consumer health industry appointments: Boiron hires former Henkel exec as CEO; Dr. Theiss Naturwaren names managing director; ProBiotix Health adds scientific expertise.

People On The Move: Appointments at CHP Australia, Opella, Ascendis

 
• By 

Round-up of the latest people moves: CHP Australia names new chief exec; Opella appoints Vietnam head; Ascendis makes permanent CFO appointment.


Bayer Drops Plan For EU OTC Antifungal Launch After Poor Trial Results

 
• By 

Bayer Consumer Health shelves European launch of topical OTC onychomycosis treatment under its Canesten brand after a Phase III trial of the product - developed by Sweden's Moberg Pharma - failed to meet its primary endpoint.

Kenvue’s Carlton Lawson: Reverse-Switching Antimicrobials ‘Not The Answer’ To AMR

 
• By 

Kenvue's EMEA and LATAM head Carlton Lawson acknowledges the urgency of environmental issues like antimicrobial resistance and wastewater pollution in this interview with HBW Insight, but calls for a more balanced approach on the part of European regulators.

People On The Move: Appointments At Haleon, Stada, Aker BioMarine

 
• By 

A round-up of the latest European consumer health industry appointments: Haleon adds to board; Stada names investor relations head; Aker BioMarine hires marketing expert.

France's Unither Acquires Virus-Blocking Nasal Spray From Marinomed

 
• By 

French CDMO Unither has snapped up Marinomed's Carragelose virus-blocking compound, which is used in OTC nasal sprays marketed by leading consumer health players such as Perrigo and Reckitt.


A ‘Once-In-A-Lifetime Experience’ – Carlton Lawson On Kenvue’s Spin Out Journey

 
• By 

Kenvue's EMEA and LATAM head Carlton Lawson reflects on the firm's 18 months of independence, pointing to significant investments and operational improvements as key milestones on its spin out journey so far.

Growth In Germany And Italy Prompts PharmaSGP To Raise Guidance

 
• By 

PharmaSGP has added an additional €5m to the top-end of its sales guidance after recording a double-digit gain Italy and outpacing the growth of the OTC market in Germany.

23andMe Cuts 40% Of Workforce, Discontinues Drug Development

 
• By 

23andMe cut 40% of its workforce and will discontinue its therapeutic program as part of ongoing restructuring. This comes after a data breach, series of layoffs and the resignation of its board members.

Bayer Lowers Sales Guidance As It Spies ‘Early Signs’ Of Weaker Cough & Cold Season

 
• By 

A slowdown in China and the US, along with signs of a weaker cough & cold season in the latter, has led Bayer Consumer Health to lower its full-year sales guidance.


Navamedic’s OTC Sales Grow Double Digits As It Takes Eroxon To Finland

 
• By 

Finland is the latest market launch for OTC erectile dysfunction treatment Eroxon. High demand for the product in other countries, such as Norway, helped drive up Navamedic's consumer health sales in the first nine months of 2024.

People On The Move: Appointments At PharmaSGP, Stada, NèreS

 
• By 

A round-up of recent consumer health appointments: PharmaSGP names new CEO; Stada appoints Vietnam head; NèreS adds to board.

Stada Bolsters OTC Production With Romanian Site

 
• By 

Stada will ship a wide range of consumer healthcare products from its new Romanian production facility, into which the German firm has invested over €70m.

Bayer Launches ‘First-Of-Its-Kind’ PET Blister For Aleve In Netherlands

 
• By 

Bayer Consumer Health is replacing mixed material PVC blister packs with monomaterial PET blisters beginning with Aleve in the Netherlands. HBW Insight speaks to vice president and global head of design, packaging, product experience and sustainability, Chris Padain, about the "evolutionary" strategy behind the move, the complexities of choosing the right material for the right product, and the importance of industry cross-collaboration via associations like GSCF.